India Fertility Monitor Market, By Modality (Hand held and Table top), By Type (Saliva based Monitor and Urine Based Monitor ), By End User, (Hospitals, Fertility Clinics, and Homecare Settings), By Region (North India, South India, East India, West India, Central India, and North East India) is estimated to be valued at US$ 2.4 Million in 2023 and is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Key market players are focusing on adopting growth strategies, such as the launch of new products, which will drive the India fertility monitor market. For instance, in June 2020, Modern Fertility, a company that provides infertility products, announced the launch of pregnancy and ovulation tests, along with a mobile application to centralize all fertility-related data
India Fertility Monitor Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.
However, the COVID-19 pandemic had a negative impact on the India fertility monitor market, owing to suspended elective surgical interventions and consultations for the diagnosis and treatment of infertility. For instance, in September 2022, according to data provided by the National Library of Medicine, SARS-CoV2 can affect reproductive health, having potentially harmful consequences for couples seeking infertility treatment. Moreover, on March 17, 2020, the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) issued several recommendations advising all patients diagnosed with infertility, regardless of whether or not they have symptoms specific to the SARS-CoV-2 infection or the diagnosis of COVID-19, to avoid pregnancy Thus, it was recommended to suspend the beginning of new treatment series. In the case of treatments that had already started, embryo preservation procedures were recommended
India Fertility Monitor Market: Key Developments
On July 28, 2023, BPEA EQT, a private equity fund, announced the acquisition of Indira IVF, a fertility clinic, to further broaden its footprint across India and explore expansion into neighboring markets, making fertility services and reproductive health more accessible to couples.
In December 2022, Hamilton Thorne Inc., a leading manufacturer of precision laser systems, announced the acquisition of MICROPTIC S.L., a biotechnology company. The acquisition strengthens the Hamilton Thorne and Microptic Footprint in Computer-Assisted Semen Analysis (CASA) for the IVF clinic.
In May 2022, Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, announced a partnership with Turtle Health, a virtual gynecology clinic, to bring a virtual transvaginal ultrasonography solution to market that can bring the convenience of at-home testing to women.
Browse 30 Market Data Tables and 26 Figures spread through 212 Pages and in-depth TOC on “India Fertility Monitor Market”- Forecast to 2030, India Fertility Monitor Market, By Modality (Hand held and Table top), By Type (Saliva based Monitor and Urine Based Monitor), By End User, (Hospitals, Fertility Clinics, and Homecare Settings), By Region (North India, South India, East India, West India, Central India, and North East India)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/india-fertility-monitor-market-4480
Key Takeaways of the India Fertility Monitor Market:
- The India fertility monitor market is expected to exhibit a CAGR of 8.3% during the forecast period, owing to increasing inorganic growth strategies, such as partnerships by key market players to expand their product portfolio. For instance, in February 2021, FERTILITY FOCUS LIMITED, a company offering fertility products, announced a partnership with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.
- Among Type, the urine based monitor segment is expected to hold a dominant position in the India fertility monitor market during the forecast period, and this is attributed to the increasing organic growth strategies, such as product approval by regulatory authorities to expand key market players product portfolios. For instance, In March 2020, MFB Fertility, Inc., a medical company, announced the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to MFB Fertility’s Proov, a test taken at home to confirm ovulation. The diagnostic strip used for the diagnosis or presence of PdG, a urine metabolite of progesterone, a hormone released by a woman’s ovary after ovulation.
- Among regions, South India is expected to be the dominant region in the India fertility monitor market, owing to increasing product approval by regulatory authorities to expand key market players product portfolios. For instance, in November 2020, Samplytics Technologies Private Limited, a India-based medical technology company, announced that its Fertility Monitor had cleared the regulatory pathway of the U.S. Food and Drug Administration (FDA). The Initos Fertility Monitor is a small device that enables smartphones to perform lab-grade fertility diagnostic tests at home.
- Major players operating in the India fertility monitor market are Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, Aluna, and Welch Allyn
